In the current study, we report that the inhibition of TNF-α signaling in a syngeneic mouse model of breast cancer using Infliximab inhibited metastasis to the lungs by inhibiting NF-κB and LPA-ATX signaling. Here, NFKB1 is linked to breast cancer.